Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for 2B Black Bio LLP Eiko Lifesciences Ltd - 540204 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) for quarter and half year ended on Septemeber 30, 2023 Eiko Lifesciences Ltd - 540204 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Please find attached herewith details of Voting Results and Scrutinizer''s Report for Forty-Sixth Annual General Meeting of the Company Eiko Lifesciences Ltd - 540204 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to Regulation 30 of the SEBI Listing Regulations read with Part A of Schedule III, please find enclosed herewith proceeding of Forty-Sixth Annual General Meeting of the Company held today i.e., Saturday, September 23, 2023 at 12:30 PM through Video Conferencing (VC)/ Other Audio-Visual means (OVAM) Eiko Lifesciences Ltd - 540204 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement regarding Notice of 46th Annual General Meeting Eiko Lifesciences Ltd - 540204 - Reg. 34 (1) Annual Report.
Annual Report for the Financial Year 2022-23 Eiko Lifesciences Ltd - 540204 - Notice Of The 46Th Annual General Meeting Of Eiko Lifesciences Limited (Formerly Known As Narendra Investment (Delhi) Limited) For Financial Year 2022-23 As Required Under Regulation 30 Of SEBI(LODR) Regulations, 2015
We wish to inform you that 46th (Forty-Sixth) Annual General Meeting (AGM) of Members of Eiko LifeSciences Limited (Formerly Known as Narendra Investments (Delhi) Limited) will be held on Saturday, 23rd Day of September, 2023 at 12:30 p.m. (IST) through Video Conference ("VC")/ Other Audiovisuals Means ("OVAM"). Accordingly notice of 46th AGM along with explanatory Statement is enclosed for the information of stock exchanges. We request you to take the same in your records. Eiko Lifesciences Ltd - 540204 - Board Meeting Outcome for Meeting Of The Company Held On 30Th August 2023
The Board has considered and Approved the following- 1. The Board''s Report, Corporate Governance Report, Management Discussion and Analysis Report. 2. Draft notice convening 46th Annual General Meeting of the Members of the Company to be held on Saturday, 23rd September 2023 at 12.30 p.m. (IST) at the registered office of the Company through Video - Conferencing ("VC") / Other Audio-Visual Means ("OAVM"). 3. Friday, September 15, 2023, as the cut-off date to determine the entitlement of voting rights of members for E-voting. 4. Annual Report of the Company for the period ended on 31st March 2023. 5. The remote e-voting period for 46th AGM begins on Wednesday, 20th September 2023 at 9.00 a.m. (IST) and ends on Friday 22nd September 2023 at 5.00 p.m. (IST) Eiko Lifesciences Ltd - 540204 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Pursuant to Regulation 30(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that Ms. Nilima Burghate has tendered her resignation from the post of Company Secretary and Compliance Officer of Eiko LifeSciences Limited with effect from close of working hours of August 29, 2023.